CONRAY 43 (iothalamate meglumine) by Guerbet is clinical pharmacology following intravascular injection, conray is rapidly transported through the circulatory system to the kidneys and is excreted unchanged in the urine by glomerular filtration. First approved in 1962.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
CONRAY 43 (iothalamate meglumine) is an iodinated radiographic contrast medium administered by injection for diagnostic imaging. It is rapidly distributed through the circulatory system and excreted unchanged in urine by glomerular filtration, enabling visualization of the vascular system, kidneys, and brain in CT and angiographic procedures. The drug works by rendering tissues radiodense due to its high iodine content, allowing differentiation of anatomical structures during imaging.
As a legacy product approaching loss of exclusivity with minimal linked job activity, career opportunities are limited to maintenance roles rather than growth-focused positions.
CLINICAL PHARMACOLOGY Following intravascular injection, Conray is rapidly transported through the circulatory system to the kidneys and is excreted unchanged in the urine by glomerular filtration. The pharmacokinetics of intravascularly administered radiopaque contrast media are usually best…
Worked on CONRAY 43 at Guerbet? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
CONRAY 43 offers minimal career growth potential due to zero linked job openings and LOE-approaching lifecycle stage. Professionals assigned to this product should expect maintenance-mode responsibilities focused on compliance, customer support, and inventory management rather than strategic expansion or innovation.